Pharmacy Times
JANUARY 12, 2024
BrainSee creates a new standard for progression prediction in Alzheimer disease, marking a step forward in brain health management with non-invasive screening.
STAT
JANUARY 12, 2024
MINNEAPOLIS — It’s been almost four years since George Floyd was murdered here at 38th Street and Chicago Avenue, a South Minneapolis corner anchored by a convenience store, its red awning still achingly familiar from once-saturating news coverage. Now, the legions of teddy bears placed in Floyd’s honor are dusty, the paint on street murals has chipped away, and community-built planters are overgrown.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JANUARY 12, 2024
We owe it to our seniors to listen to their needs and ensure pharmacists have the support they need to continue to play a vital role in our communities as frontline providers of essential health care.
Fierce Healthcare
JANUARY 12, 2024
Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit. | Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JANUARY 12, 2024
With the increase in counterfeit GLP-1 and GLP/GIP medications available online, education may be needed for patients around the dangers of unregulated medications.
Fierce Healthcare
JANUARY 12, 2024
LAS VEGAS — With all the buzz and headlines about artificial intelligence, there is one demographic that is quietly embracing the technology and even building long-term relationships with it. | With all the buzz and headlines about artificial intelligence, there is one demographic that is quietly embracing the technology and even building long-term relationships with it.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
JANUARY 12, 2024
We've closed the books on another hectic J. | We covered some of the biggest headlines from the four-day conference and after parsing through all the presentations, interviews and panel discussions, we tracked a handful of key trends dominating the conversations.
STAT
JANUARY 12, 2024
Though the Covid-19 pandemic brought heightened attention to nurses overall, a unique nursing role has been long overlooked and, for the public, largely misunderstood: that of the nurse manager. Like nurses in other roles, nurse managers are increasingly leaving their jobs — and it’s critically important for organizations to find ways to keep them.
Pharmacy Times
JANUARY 12, 2024
The results also indicated that stress and blood sugar levels were higher among women who had a college degree and women with a higher income.
Drug Topics
JANUARY 12, 2024
The proprietary disposable insulin delivery system promises to be a more convenient, individualized, and accessible treatment option for patients with diabetes.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JANUARY 12, 2024
In the latest bid to lower the cost of medicines, a new bill was introduced in Congress that would make it harder for pharmaceutical companies to use numerous patents in order to thwart generic competition. The legislation , which was introduced in both the House and the Senate, addresses the use of so-called patent thickets. This refers to a widely used tactic in which a drug company obtains numerous patents — sometimes, numbering in the dozens — to protect its monopoly on a medic
Fierce Healthcare
JANUARY 12, 2024
A MedPAC meeting on the status of Medicare Advantage held Friday began with numbers on enrollment and insights into coding diagnoses, before devolving into contentious debate over the quality of th | Spirited disagreement arose during MedPAC's Medicare Advantage sessions on Friday, as members debated the merits of the program.
Pharmacy Times
JANUARY 12, 2024
RSV could interact with nerve cells, causing nerve damage and possible entry to the spinal cord.
Fierce Healthcare
JANUARY 12, 2024
Though prescriptions for antiviral influenza medications have declined somewhat since 2023, perhaps indicating that the United States might be less encumbered by the flu than in recent
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JANUARY 12, 2024
Explore the trends and challenges in the pharmaceutical and healthcare markets, specifically focusing on phase change and the complexities of scaling up operations. Gain insights into the evolving landscape of the industry as we look ahead to 2024.
Fierce Healthcare
JANUARY 12, 2024
While market pressures have often left payers and providers at odds in contract negotiations, leaders at Trinity Health and Anthem Blue Cross said that things don't always have to be this way. | The two announced Thursday that they had reached an agreement to extend their network agreement for multiple years.
Fierce Pharma
JANUARY 12, 2024
When a plaintiff raises allegations of negligence against a company, the claims typically center on defective products that can cause harm. | A group of 24,000 users of Gilead's TDF-based HIV meds argue that the company knowingly shelved a safer HIV med to increase its profits. Now, Gilead will have to prove that a manufacturer can't be held liable for its development timeline of an upgraded product.
STAT
JANUARY 12, 2024
Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks. The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies.
pharmaphorum
JANUARY 12, 2024
AI technology is revolutionising the field of clinical trials by enhancing patient identification, accelerating drug development and design, and improving monitoring processes. Discover how AI is supercharging clinical trials for better healthcare outcomes.
Fierce Pharma
JANUARY 12, 2024
A preliminary evaluation by the FDA found no evidence that use of popular diabetes and weight-loss drugs from Novo Nordisk and Eli Lilly can cause suicidal thoughts, the U.S. | A preliminary evaluation by the FDA found no evidence that use of popular diabetes and weight-loss drugs from Novo Nordisk and Eli Lilly can cause suicidal thoughts, the U.S. regulator said.
The Checkup by Singlecare
JANUARY 12, 2024
Wegovy (the brand name for the active ingredient semaglutide) is an injectable drug prescribed for chronic weight management, used in tandem with lifestyle changes including a reduced-calorie diet and increased physical activity. It works by mimicking a hormone in the body called glucagon-like peptide-1 (GLP-1), which helps curb hunger and increase satiety.
pharmaphorum
JANUARY 12, 2024
Discover how Veeva Systems is revolutionising closed loop marketing and connectivity in biopharma, from clinical to medical. Learn more about innovative solutions and insights from the Veeva Commercial Summit, featuring industry expert Chris Moore and the power of data-driven strategies.
Pharmaceutical Commerce
JANUARY 12, 2024
An overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.
pharmaphorum
JANUARY 12, 2024
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has started a review of the generic and – if approved – Lantheus could be in line for 180 days of market exclusivity as the first company to bring a copycat version of Lutathera (lutetium Lu 177 dotatate) to the US market.
Drug Topics
JANUARY 12, 2024
Regulators will continue to conduct additional evaluations to assess the link between GLP-1 dugs and suicidal thoughts or actions.
pharmaphorum
JANUARY 12, 2024
Researchers from the Wellcome Sanger Institute and partners have carried out a comprehensive analysis of cancer cells, identifying 370 ‘priority’ targets that could be used to develop new drug therapies.
STAT
JANUARY 12, 2024
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.
Drug Topics
JANUARY 12, 2024
A new study found that SARS-CoV-2 RNA was correlated with incident COVID-19 cases at the school level.
STAT
JANUARY 12, 2024
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do expect to promenade extensively with the official mascots, catch up on our reading, and sample different types of food here and there. We also hope to hold another listening party with Mrs.
Drug Store News
JANUARY 12, 2024
Cherry Vanilla will now be a shade in the Forget the Filler Lip Plumping Balm Stick family and part of the Queen-Sized Forget the Fuller Plumping Gloss collection.
European Pharmaceutical Review
JANUARY 12, 2024
Using an investment of €120 million, Boehringer Ingelheim is set to expand and upgrade its production site in Koropi, Greece. New technologies at the facility will support the increased manufacturing capacity, the company stated on X. The expansion will boost exports of medicines from Greece to the US market. This will be the case particularly for Jardiance ® , a treatment for type 2 diabetes, chronic heart failure and chronic kidney disease (CKD), according to Boehringer Ingelheim.
Drug Store News
JANUARY 12, 2024
The brand is partnering with comedian Pete Davidson on a campaign that looks to dethrone flat pizza and help fans experience game day with its infamous Pizza Rolls.
pharmaphorum
JANUARY 12, 2024
The FDA says it can find no evidence of increased risk of suicidal thoughts and self-harm with GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy
Drug Store News
JANUARY 12, 2024
The partnership transforms Hy-Vee stores into points of care for Medicaid, Medicare and other health insurance members to redeem benefits for nutritional support, medications and more.
Expert insights. Personalized for you.
178 
Let's personalize your content